Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
3.350
-0.009 (-0.27%)
Oct 27, 2026, 4:00 PM EDT - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $10.78 million as of October 27, 2026. It is the 41,011th most valuable company in the world and the 5,548th biggest in the United States. Its market cap has decreased by 52.52% in one year.
Market Cap
10.78M
Enterprise Value
-13.38M
1-Year Change
-52.52%
Global Rank
Country Rank
#5,548 United States
Category
ChartMarket Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $10.78M, a decrease of -98.87%. That is a compound annual growth rate of -48.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 10.78M | -71.26% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 11.54M |
| Psyence Biomedical | 11.48M |
| Cellectar Biosciences | 11.44M |
| Radiopharm Theranostics | 11.00M |
| Karyopharm Therapeutics | 10.89M |
| BioVie | 10.86M |
| CytoMed Therapeutics | 10.62M |
| Purple Biotech | 10.49M |